Hiroshi Mitsumoto

Amyotrophic-Lateral-SclerosisSince publication of the last edition, our understanding and treatment of ALS have changed dramatically. The many puzzles of this disease are being steadily solved. A number of causes of familial ALS have been identified, and the mechanisms of motor neuron cell death are much better understood. The FDA approved riluzole in 1996 as the first drug ever approved for the treatment of ALS. Although expected for the past dozen years, it is frustrating to say that additional drugs have not been developed. Yet, new drugs continue to be tested and others are on the horizon.

3 thoughts on “Hiroshi Mitsumoto

  1. shinichi Post author

    MitsumotoAmyotrophic Lateral Sclerosis

    by Hiroshi Mitsumoto

    (2009)

    ALS, also known as Lou Gehrig’s disease, cannot be cured but it can be treated. A great deal can be done to treat the symptoms of ALS, to improve an individual’s quality of life, and to help families, caregivers, and loved ones to cope with the disease. This extensively revised and rewritten new edition of the bestselling Amyotrophic Lateral Sclerosis: A Guide For Patients and Families addresses all of those needs, and brings up-to-date important information to those living with the reality of ALS.

    The book is completely revised throughout and contains NEW information on:
    ・ Recently developed approaches to treating ALS symptoms
    ・ Use of non-invasive ventilators
    ・ Multidisciplinary team care
    ・ New guidelines being developed by the American Academy of Neurology for patients with ALS
    ・ The use of riluzole (Rilutek) to treat ALS

    Amyotrophic Lateral Sclerosis covers every aspect of the management of ALS, from clinical features of the disease, to diagnosis, to an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and assistance in this time of need.

    Reply

Leave a Reply to shinichi Cancel reply

Your email address will not be published. Required fields are marked *